{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:07:48Z","timestamp":1792591668176,"version":"4.5.0"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"DOI":"10.1186\/s13643-024-02684-0","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T07:59:03Z","timestamp":1734508743000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["The best ovarian reserve marker to predict ovarian response following controlled ovarian hyperstimulation: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4297-7154","authenticated-orcid":false,"given":"Fateme","family":"Salemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8295-7812","authenticated-orcid":false,"given":"Sara","family":"Jambarsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Kheirkhah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Salehi-Abargouei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Ahmadnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haniye Ali","family":"hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzieh","family":"Lotfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Amer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"issue":"6","key":"2684_CR1","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1093\/humupd\/dml034","volume":"12","author":"FJ Broekmans","year":"2006","unstructured":"Broekmans FJ, et al. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006;12(6):685\u2013718.","journal-title":"Hum Reprod Update"},{"key":"2684_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.702061","volume":"12","author":"X Wang","year":"2021","unstructured":"Wang X, et al. Evaluation of ovarian reserve tests and age in the prediction of poor ovarian response to controlled ovarian stimulation-a real-world data analysis of 89,002 patients. Front Endocrinol (Lausanne). 2021;12: 702061.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"2684_CR3","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1016\/j.fertnstert.2014.12.103","volume":"103","author":"Medicine, P.C.o.t.A.S.f.R","year":"2015","unstructured":"Medicine, P.C.o.t.A.S.f.R. Diagnostic evaluation of the infertile male: a committee opinion. Fertility and sterility. 2015;103(3):e18\u201325.","journal-title":"Fertility and sterility"},{"key":"2684_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.672890","volume":"9","author":"SJ Chon","year":"2021","unstructured":"Chon SJ, Umair Z, Yoon M-S. Premature ovarian insufficiency: past, present, and future. Frontiers in cell and developmental biology. 2021;9: 672890.","journal-title":"Frontiers in cell and developmental biology"},{"issue":"2","key":"2684_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.4103\/0974-1208.183514","volume":"9","author":"PR Jirge","year":"2016","unstructured":"Jirge PR. Poor ovarian reserve. J Hum Reprod Sci. 2016;9(2):63\u20139.","journal-title":"J Hum Reprod Sci"},{"key":"2684_CR6","doi-asserted-by":"crossref","unstructured":"Man L, et al.\u00a0Ovarian reserve disorders, can we prevent them? A review. Int J Mol Sci. 2022;23(23):15426.","DOI":"10.3390\/ijms232315426"},{"issue":"2","key":"2684_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.4103\/0974-1208.183514","volume":"9","author":"PR Jirge","year":"2016","unstructured":"Jirge PR. Poor ovarian reserve. Journal of human reproductive sciences. 2016;9(2):63.","journal-title":"Journal of human reproductive sciences"},{"issue":"3","key":"2684_CR8","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.fertnstert.2014.12.093","volume":"103","author":"Medicine, P.C.o.t.A.S.f.R","year":"2015","unstructured":"Medicine, P.C.o.t.A.S.f.R. Fertility and sterility. Fertility and sterility. 2015;103(3):e9\u201317.","journal-title":"Fertility and sterility"},{"key":"2684_CR9","doi-asserted-by":"crossref","unstructured":"Koert, E., et al., Women\u2019s perceptions of fertility assessment and counselling 6 years after attending a Fertility Assessment and Counselling Clinic in Denmark. Hum Reprod Open, 2020. 2020(4): p. hoaa036.","DOI":"10.1093\/hropen\/hoaa036"},{"issue":"2","key":"2684_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ajog.2017.02.027","volume":"217","author":"R Tal","year":"2017","unstructured":"Tal R, Seifer DB. Ovarian reserve testing: a user\u2019s guide. Am J Obstet Gynecol. 2017;217(2):129\u201340.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"2684_CR11","doi-asserted-by":"publisher","first-page":"108","DOI":"10.4103\/0974-1208.92283","volume":"4","author":"PR Jirge","year":"2011","unstructured":"Jirge PR. Ovarian reserve tests. Journal of human reproductive sciences. 2011;4(3):108.","journal-title":"Journal of human reproductive sciences"},{"issue":"1","key":"2684_CR12","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S1472-6483(10)60808-5","volume":"10","author":"J Galey-Fontaine","year":"2005","unstructured":"Galey-Fontaine J, et al. Age and ovarian reserve are distinct predictive factors of cycle outcome in low responders. Reprod Biomed Online. 2005;10(1):94\u20139.","journal-title":"Reprod Biomed Online"},{"issue":"8 Supplement","key":"2684_CR13","first-page":"3342s","volume":"42","author":"KJ Ryan","year":"1982","unstructured":"Ryan KJ. Biochemistry of aromatase: significance to female reproductive physiology. Can Res. 1982;42(8 Supplement):3342s\u20134s.","journal-title":"Can Res"},{"issue":"1","key":"2684_CR14","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/humrep\/dem254","volume":"23","author":"T-H Lee","year":"2008","unstructured":"Lee T-H, et al. Serum anti-M\u00fcllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles. Hum Reprod. 2008;23(1):160\u20137.","journal-title":"Hum Reprod"},{"issue":"7","key":"2684_CR15","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1007\/s43032-021-00483-9","volume":"28","author":"A Aflatoonian","year":"2021","unstructured":"Aflatoonian A, et al. Effects of intraovarian injection of autologous platelet-rich plasma on ovarian rejuvenation in poor responders and women with primary ovarian insufficiency. Reprod Sci. 2021;28(7):2050\u20139.","journal-title":"Reprod Sci"},{"issue":"1","key":"2684_CR16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/humupd\/dmt037","volume":"20","author":"A La Marca","year":"2014","unstructured":"La Marca A, Sunkara SK. Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice. Hum Reprod Update. 2014;20(1):124\u201340.","journal-title":"Hum Reprod Update"},{"issue":"2","key":"2684_CR17","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/humupd\/dmp036","volume":"16","author":"A La Marca","year":"2010","unstructured":"La Marca A, et al. Anti-M\u00fcllerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2010;16(2):113\u201330.","journal-title":"Hum Reprod Update"},{"key":"2684_CR18","doi-asserted-by":"crossref","unstructured":"Jamil Z, et al. Anti-Mullerian hormone: above and beyond conventional ovarian reserve markers. Dis Markers. 2016;2016(1):5246217.","DOI":"10.1155\/2016\/5246217"},{"issue":"12","key":"2684_CR19","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1093\/humrep\/del291","volume":"21","author":"A La Marca","year":"2006","unstructured":"La Marca A, et al. Serum anti-Mullerian hormone throughout the human menstrual cycle. Hum Reprod. 2006;21(12):3103\u20137.","journal-title":"Hum Reprod"},{"issue":"6","key":"2684_CR20","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1016\/j.fertnstert.2007.10.028","volume":"90","author":"K Jayaprakasan","year":"2008","unstructured":"Jayaprakasan K, et al. Establishing the intercycle variability of three-dimensional ultrasonographic predictors of ovarian reserve. Fertil Steril. 2008;90(6):2126\u201332.","journal-title":"Fertil Steril"},{"issue":"3","key":"2684_CR21","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S0002-9378(98)70087-0","volume":"179","author":"FI Sharara","year":"1998","unstructured":"Sharara FI, Scott RT Jr, Seifer DB. The detection of diminished ovarian reserve in infertile women. Am J Obstet Gynecol. 1998;179(3):804\u201312.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2684_CR22","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/humupd\/dmq034","volume":"17","author":"S Broer","year":"2011","unstructured":"Broer S, et al. AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis. Hum Reprod Update. 2011;17(1):46\u201354.","journal-title":"Hum Reprod Update"},{"issue":"2","key":"2684_CR23","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.fertnstert.2013.04.024","volume":"100","author":"S.L Broer","year":"2013","unstructured":"Broer S.L, et al. Prediction of an excessive response in in vitro fetilization from patient characteristics and ovarian reserve test and comparison in subgroups: an individual patient data meta-analysis. Fertility and sterility. 2013;100(2):420-429. e7.","journal-title":"Fertility and sterility"},{"key":"2684_CR24","doi-asserted-by":"crossref","unstructured":"Tal, R., et al., AntiM\u00fcllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis. Fertility and sterility, 2015. 103(1): p. 119\u2013130. e3.","DOI":"10.1016\/j.fertnstert.2014.09.041"},{"issue":"1","key":"2684_CR25","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/EDE.0b013e3181fe7825","volume":"22","author":"D Moher","year":"2011","unstructured":"Moher D, et al. PRISMA statement. Epidemiology. 2011;22(1):128.","journal-title":"Epidemiology"},{"issue":"12","key":"2684_CR26","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1007\/s10815-015-0595-y","volume":"32","author":"J Cohen","year":"2015","unstructured":"Cohen J, Chabbert-Buffet N, Darai E. Diminished ovarian reserve, premature ovarian failure, poor ovarian responder\u2014a plea for universal definitions. J Assist Reprod Genet. 2015;32(12):1709\u201312.","journal-title":"J Assist Reprod Genet"},{"key":"2684_CR27","doi-asserted-by":"crossref","unstructured":"Gunning M, et al. Premature ovarian insufficiency. Female Reprod Dysfunction. 2020:287\u2013307.","DOI":"10.1007\/978-3-030-14782-2_15"},{"issue":"6","key":"2684_CR28","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/humupd\/dmr034","volume":"17","author":"S Altm\u00e4e","year":"2011","unstructured":"Altm\u00e4e S, et al. Genetic predictors of controlled ovarian hyperstimulation: where do we stand today? Hum Reprod Update. 2011;17(6):813\u201328.","journal-title":"Hum Reprod Update"},{"issue":"6","key":"2684_CR29","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1093\/humrep\/13.6.1553","volume":"13","author":"BJ Cohlen","year":"1998","unstructured":"Cohlen BJ, et al. Controlled ovarian hyperstimulation and intrauterine insemination for treating male subfertility: a controlled study. Human reproduction (Oxford, England). 1998;13(6):1553\u20138.","journal-title":"Human reproduction (Oxford, England)"},{"issue":"8","key":"2684_CR30","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529\u201336.","journal-title":"Ann Intern Med"},{"key":"2684_CR31","unstructured":"Amer Abed, F., R. Ezzat Maroof, and U.M.A. Al-Nakkash, Comparing the diagnostic accuracy of anti-Mullerian hormone and follicle stimulating hormone in detecting premature ovarian failure in Iraqi women by ROC analysis. Rep Biochem Mol Biol, 2019. 8(2): p. 126\u2013131."},{"issue":"7","key":"2684_CR32","doi-asserted-by":"publisher","first-page":"E1030","DOI":"10.1210\/jc.2015-1621","volume":"100","author":"SA Lunding","year":"2015","unstructured":"Lunding SA, et al. AMH as predictor of premature ovarian insufficiency: a longitudinal study of 120 Turner syndrome patients. J Clin Endocrinol Metab. 2015;100(7):E1030\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"2684_CR33","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/585604","volume":"2015","author":"F Alipour","year":"2015","unstructured":"Alipour F, et al. Comparison of specificity and sensitivity of AMH and FSH in diagnosis of premature ovarian failure. Dis Markers. 2015;2015: 585604.","journal-title":"Dis Markers"},{"issue":"4","key":"2684_CR34","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.fertnstert.2013.12.039","volume":"101","author":"DE Reichman","year":"2014","unstructured":"Reichman DE, Goldschlag D, Rosenwaks Z. Value of antim\u00fcllerian hormone as a prognostic indicator of in vitro fertilization outcome. Fertil Steril. 2014;101(4):1012-1018.e1.","journal-title":"Fertil Steril"},{"issue":"3","key":"2684_CR35","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1093\/humrep\/der473","volume":"27","author":"S Kallio","year":"2012","unstructured":"Kallio S, et al. Anti-Mullerian hormone as a predictor of follicular reserve in ovarian insufficiency: special emphasis on FSH-resistant ovaries. Hum Reprod. 2012;27(3):854\u201360.","journal-title":"Hum Reprod"},{"issue":"2","key":"2684_CR36","first-page":"57","volume":"4","author":"R Nikbakht","year":"2010","unstructured":"Nikbakht R, Borhani M, Sarvestani GY. Evaluation of ovarian reserve by measurement of the serum levels of anti-mullerian hormone and follicle-stimulating hormone in intracytoplasmic sperm injection cycles. International Journal of Fertility and Sterility. 2010;4(2):57\u201360.","journal-title":"International Journal of Fertility and Sterility"},{"issue":"6","key":"2684_CR37","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1016\/j.fertnstert.2009.12.002","volume":"94","author":"C Kaya","year":"2010","unstructured":"Kaya C, Pabuccu R, Satiroglu H. Serum antimullerian hormone concentrations on day 3 of the in vitro fertilization stimulation cycle are predictive of the fertilization, implantation, and pregnancy in polycystic ovary syndrome patients undergoing assisted reproduction. Fertil Steril. 2010;94(6):2202\u20137.","journal-title":"Fertil Steril"},{"issue":"5","key":"2684_CR38","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1080\/01443615.2021.2003309","volume":"42","author":"K Aslan","year":"2022","unstructured":"Aslan K, et al. Which is more predictive ovarian sensitivity marker if there is discordance between serum anti-M\u00fcllerian hormone levels and antral follicle count? A retrospective analysis J Obstet Gynaecol. 2022;42(5):1461\u20136.","journal-title":"A retrospective analysis J Obstet Gynaecol"},{"issue":"2","key":"2684_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogoh.2021.102289","volume":"51","author":"P Barri\u00e8re","year":"2022","unstructured":"Barri\u00e8re P, et al. Added value of anti-M\u00fcllerian hormone serum concentration in assisted reproduction clinical practice using highly purified human menopausal gonadotropin (HP-hMG). J Gynecol Obstet Hum Reprod. 2022;51(2): 102289.","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"1","key":"2684_CR40","first-page":"38","volume":"25","author":"Z Heidary","year":"2024","unstructured":"Heidary Z, et al. The association of AMH level with the number and quality of oocytes in women undergoing IVF\/ICSI: a single-center study. Journal of Reproduction and Infertility. 2024;25(1):38\u201345.","journal-title":"Journal of Reproduction and Infertility"},{"key":"2684_CR41","doi-asserted-by":"crossref","unstructured":"Jabarpour M, et al. High anti-M\u00fcllerian hormone strongly correlates with reproductive outcomes in women undergoing assisted reproduction. Clin Lab. 2023;69(12).","DOI":"10.7754\/Clin.Lab.2023.230524"},{"issue":"1","key":"2684_CR42","first-page":"40","volume":"15","author":"W Permadi","year":"2021","unstructured":"Permadi W, et al. Correlation of anti-Mullerian hormone level and antral follicle count with oocyte number in a fixed-dose controlled ovarian hyperstimulation of patients of in vitro fertilization program. International Journal of Fertility and Sterility. 2021;15(1):40\u20133.","journal-title":"International Journal of Fertility and Sterility"},{"issue":"9","key":"2684_CR43","volume":"14","author":"S Sinha","year":"2022","unstructured":"Sinha S, Sharan A, Sinha S. Anti-Mullerian hormone as a marker of ovarian reserve and function. Cureus. 2022;14(9): e29214.","journal-title":"Cureus"},{"issue":"6","key":"2684_CR44","first-page":"470","volume":"94","author":"PP Sun","year":"2023","unstructured":"Sun PP, et al. The relationship between serum FSH level and ovarian response during controlled ovarian stimulation. Ginekol Pol. 2023;94(6):470\u20135.","journal-title":"Ginekol Pol"},{"issue":"7","key":"2684_CR45","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1007\/s10815-021-02217-x","volume":"38","author":"S Vagios","year":"2021","unstructured":"Vagios S, et al. Response to ovulation induction treatments in women with polycystic ovary syndrome as a function of serum anti-M\u00fcllerian hormone levels. J Assist Reprod Genet. 2021;38(7):1827\u201333.","journal-title":"J Assist Reprod Genet"},{"issue":"1","key":"2684_CR46","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.rbmo.2023.03.004","volume":"47","author":"M Zajicek","year":"2023","unstructured":"Zajicek M, et al. Evaluation of ovarian reserve in young females with non-iatrogenic ovarian insufficiency to establish criteria for ovarian tissue cryopreservation. Reprod Biomed Online. 2023;47(1):102\u20139.","journal-title":"Reprod Biomed Online"},{"issue":"9","key":"2684_CR47","doi-asserted-by":"publisher","first-page":"826","DOI":"10.3109\/09513590.2013.813466","volume":"29","author":"A El-Mazny","year":"2013","unstructured":"El-Mazny A, Abou-Salem N. Anti-M\u00fcllerian hormone and antral follicle count for prediction of ovarian stimulation response in polycystic ovary syndrome. Gynecol Endocrinol. 2013;29(9):826\u20139.","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"2684_CR48","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.fertnstert.2003.06.011","volume":"81","author":"L Bancsi","year":"2004","unstructured":"Bancsi L, et al. Impact of repeated antral follicle counts on the prediction of poor ovarian response in women undergoing in vitro fertilization. Fertil Steril. 2004;81(1):35\u201341.","journal-title":"Fertil Steril"},{"issue":"3","key":"2684_CR49","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/S0015-0282(16)58159-X","volume":"65","author":"T Mukherjee","year":"1996","unstructured":"Mukherjee T, et al. An elevated day three follicle-stimulating hormone:luteinizing hormone ratio (FSH:LH) in the presence of a normal day 3 FSH predicts a poor response to controlled ovarian hyperstimulation. Fertil Steril. 1996;65(3):588\u201393.","journal-title":"Fertil Steril"},{"issue":"1","key":"2684_CR50","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/humrep\/deh553","volume":"20","author":"DJ Hendriks","year":"2005","unstructured":"Hendriks DJ, et al. Repeated clomiphene citrate challenge testing in the prediction of outcome in IVF: a comparison with basal markers for ovarian reserve. Hum Reprod. 2005;20(1):163\u20139.","journal-title":"Hum Reprod"},{"key":"2684_CR51","doi-asserted-by":"crossref","unstructured":"Xu X, et al. Development and validation of a prediction model for unexpected poor ovarian response during IVF\/ICSI. Front Endocrinol. 2024;15:1340329.","DOI":"10.3389\/fendo.2024.1340329"},{"key":"2684_CR52","doi-asserted-by":"crossref","unstructured":"Yan Y, et al. Clinical features and management of suboptimal ovarian response during in vitro fertilization and embryo transfer: analysis based on a retrospective cohort study. Front Endocrinol. 2022;13:938926.","DOI":"10.3389\/fendo.2022.938926"},{"issue":"5","key":"2684_CR53","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.rbmo.2018.12.041","volume":"38","author":"MH Jacobs","year":"2019","unstructured":"Jacobs MH, et al. A multicentre evaluation of the Elecsys \u00ae anti-M\u00fcllerian hormone immunoassay for prediction of antral follicle count. Reprod Biomed Online. 2019;38(5):845\u201352.","journal-title":"Reprod Biomed Online"},{"issue":"2","key":"2684_CR54","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3109\/13697137.2013.870149","volume":"17","author":"S Sahmay","year":"2014","unstructured":"Sahmay S, et al. Elevated LH levels draw a stronger distinction than AMH in premature ovarian insufficiency. Climacteric. 2014;17(2):197\u2013203.","journal-title":"Climacteric"},{"issue":"3","key":"2684_CR55","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.mefs.2010.06.009","volume":"15","author":"F Fouda","year":"2010","unstructured":"Fouda F, et al. Anti-mullerian hormone level is a reliable predictor for cycle cancellation in ICSI. Middle East Fertility Society Journal. 2010;15(3):194\u20139.","journal-title":"Middle East Fertility Society Journal"},{"issue":"4","key":"2684_CR56","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.mefs.2018.01.012","volume":"23","author":"NM Rashad","year":"2018","unstructured":"Rashad NM, et al. Anti-M\u00fcllerian hormone: predictor of premature ovarian insufficiency in Egyptian women with autoimmune thyroiditis. Middle East Fertility Society Journal. 2018;23(4):286\u201391.","journal-title":"Middle East Fertility Society Journal"},{"issue":"9","key":"2684_CR57","first-page":"1866","volume":"7","author":"P Saikumar","year":"2013","unstructured":"Saikumar P, et al. Anti Mullerian hormone: a potential marker for recruited non growing follicle of ovarian pool in women with polycystic ovarian syndrome. J Clin Diagn Res. 2013;7(9):1866\u20139.","journal-title":"J Clin Diagn Res"},{"issue":"4","key":"2684_CR58","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.rbmo.2010.11.005","volume":"22","author":"A La Marca","year":"2011","unstructured":"La Marca A, et al. Anti-M\u00fcllerian hormone-based prediction model for a live birth in assisted reproduction. Reprod Biomed Online. 2011;22(4):341\u20139.","journal-title":"Reprod Biomed Online"},{"issue":"7","key":"2684_CR59","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1016\/j.fertnstert.2010.04.067","volume":"94","author":"N Gleicher","year":"2010","unstructured":"Gleicher N, Weghofer A, Barad DH. Anti-M\u00fcllerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserve. Fertil Steril. 2010;94(7):2824\u20137.","journal-title":"Fertil Steril"},{"issue":"3","key":"2684_CR60","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.fertnstert.2015.06.018","volume":"104","author":"HR Burks","year":"2015","unstructured":"Burks HR, et al. Can highly sensitive antim\u00fcllerian hormone testing predict failed response to ovarian stimulation? Fertil Steril. 2015;104(3):643\u20138.","journal-title":"Fertil Steril"},{"issue":"1","key":"2684_CR61","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/humrep\/dem254","volume":"23","author":"TH Lee","year":"2008","unstructured":"Lee TH, et al. Serum anti-Mullerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles. Hum Reprod. 2008;23(1):160\u20137.","journal-title":"Hum Reprod"},{"issue":"5","key":"2684_CR62","doi-asserted-by":"publisher","first-page":"663","DOI":"10.12891\/ceog1975.2015","volume":"42","author":"T Aydin","year":"2015","unstructured":"Aydin T, et al. The association between anti-M\u00fcllerian hormone and IVF-ICSI outcome in poor responder patients performing long protocol. Clin Exp Obstet Gynecol. 2015;42(5):663\u20135.","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"3","key":"2684_CR63","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/rmb2.12271","volume":"18","author":"Y Asada","year":"2019","unstructured":"Asada Y, et al. Performance of anti-M\u00fcllerian hormone (AMH) levels measured by Beckman Coulter Access AMH assay to predict oocyte yield following controlled ovarian stimulation for in vitro fertilization. Reproductive Medicine and Biology. 2019;18(3):273\u20137.","journal-title":"Reproductive Medicine and Biology"},{"issue":"2","key":"2684_CR64","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.rbmo.2022.10.012","volume":"46","author":"E Bosch","year":"2023","unstructured":"Bosch E, et al. Prediction of ovarian response using the automated Elecsys anti-M\u00fcllerian hormone assay in gonadotrophin-releasing hormone antagonist cycles. Reprod Biomed Online. 2023;46(2):295\u2013301.","journal-title":"Reprod Biomed Online"},{"issue":"12","key":"2684_CR65","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1080\/09513590.2022.2154339","volume":"38","author":"S Peralta","year":"2022","unstructured":"Peralta S, et al. Antral follicle count measured at down-regulation as predictor of ovarian response and cumulative live birth: single center analysis including 2731 long agonist IVF cycles. Gynecol Endocrinol. 2022;38(12):1079\u201386.","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"2684_CR66","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s10815-024-03050-8","volume":"41","author":"A Hochberg","year":"2024","unstructured":"Hochberg A, et al. Significance of serum AMH and antral follicle count discrepancy for the prediction of ovarian stimulation response in Poseidon criteria patients. J Assist Reprod Genet. 2024;41(3):717\u201326.","journal-title":"J Assist Reprod Genet"},{"key":"2684_CR67","unstructured":"Jabir Edan B, Mahdi Kadhim H, Resheed Behayaa H. Sensitivity and specificity of measuring anti-M\u00fcllerian hormone and follicle stimulating hormone levels in predicting response to ovarian stimulation in infertile women. J Babol Univ Med Sci.\u00a02024;26:0."},{"key":"2684_CR68","doi-asserted-by":"crossref","unstructured":"Razafintsalama-Bourdet M, et al. Random antral follicle count performed on any day of the menstrual cycle has the same predictive value as AMH for good ovarian response in IVF cycles. J Gynecol Obstet Hum Reproduct. 2022;51(1):102233.","DOI":"10.1016\/j.jogoh.2021.102233"},{"issue":"13","key":"2684_CR69","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006495","volume":"96","author":"H Zheng","year":"2017","unstructured":"Zheng H, et al. Ovarian response prediction in controlled ovarian stimulation for IVF using anti-Mullerian hormone in Chinese women: a retrospective cohort study. Medicine (Baltimore). 2017;96(13): e6495.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"2684_CR70","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.rbmo.2017.02.012","volume":"34","author":"T Lerman","year":"2017","unstructured":"Lerman T, et al. Ovarian response to 150 \u00b5g corifollitropin alfa in a GnRH-antagonist multiple-dose protocol: a prospective cohort study. Reprod Biomed Online. 2017;34(5):534\u201340.","journal-title":"Reprod Biomed Online"},{"issue":"4","key":"2684_CR71","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.rbmo.2016.07.003","volume":"33","author":"R Li","year":"2016","unstructured":"Li R, et al. Anti-M\u00fcllerian hormone for prediction of ovarian response in Chinese infertile women undergoing IVF\/ICSI cycles: a prospective, multi-centre, observational study. Reprod Biomed Online. 2016;33(4):506\u201312.","journal-title":"Reprod Biomed Online"},{"key":"2684_CR72","doi-asserted-by":"crossref","unstructured":"Aghssa MM, et al. Optimal cutoff value of basal anti-mullerian hormone in iranian infertile women for prediction of ovarian hyper-stimulation syndrome and poor response to stimulation female fertility. Reprod Health. 2015;12:1\u20138.","DOI":"10.1186\/s12978-015-0053-4"},{"issue":"6","key":"2684_CR73","first-page":"371","volume":"70","author":"M Mehrafza","year":"2012","unstructured":"Mehrafza M, et al. Anti-m\u00fcllerian hormone as a predictor of IVF treatment. Tehran University Medical Journal. 2012;70(6):371\u20137.","journal-title":"Tehran University Medical Journal"},{"issue":"5","key":"2684_CR74","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.fertnstert.2008.08.127","volume":"92","author":"LG Nardo","year":"2009","unstructured":"Nardo LG, et al. Circulating basal anti-M\u00fcllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization. Fertil Steril. 2009;92(5):1586\u201393.","journal-title":"Fertil Steril"},{"issue":"2","key":"2684_CR75","doi-asserted-by":"publisher","first-page":"202.e1","DOI":"10.1016\/j.ajog.2008.05.004","volume":"199","author":"RM Riggs","year":"2008","unstructured":"Riggs RM, et al. Assessment of ovarian reserve with anti-Mullerian hormone: a comparison of the predictive value of anti-Mullerian hormone, follicle-stimulating hormone, inhibin B, and age. Am J Obstet Gynecol. 2008;199(2):202.e1-8.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2684_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43043-021-00062-7","volume":"26","author":"MM Laqqan","year":"2021","unstructured":"Laqqan MM, Yassin MM. Predictive factors of ovarian response to GnRH antagonist stimulation protocol: AMH and age are potential candidates. Middle East Fertility Society Journal. 2021;26(1):1\u201311.","journal-title":"Middle East Fertility Society Journal"},{"issue":"4","key":"2684_CR77","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1080\/09513590.2020.1786509","volume":"37","author":"C Peluso","year":"2021","unstructured":"Peluso C, et al. Are ovarian reserve tests reliable in predicting ovarian response? Results from a prospective, cross-sectional, single-center analysis. Gynecol Endocrinol. 2021;37(4):358\u201366.","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"2684_CR78","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.rbmo.2020.03.023","volume":"41","author":"AR Neves","year":"2020","unstructured":"Neves AR, et al. The performance of the Elecsys\u00ae anti-M\u00fcllerian hormone assay in predicting extremes of ovarian response to corifollitropin alfa. Reprod Biomed Online. 2020;41(1):29\u201336.","journal-title":"Reprod Biomed Online"},{"issue":"9","key":"2684_CR79","doi-asserted-by":"publisher","first-page":"463","DOI":"10.11622\/smedj.2020130","volume":"61","author":"RWK Lee","year":"2020","unstructured":"Lee RWK, et al. Ovarian biomarkers predict controlled ovarian stimulation for in vitro fertilisation treatment in Singapore. Singapore Med J. 2020;61(9):463\u20138.","journal-title":"Singapore Med J"},{"issue":"5","key":"2684_CR80","doi-asserted-by":"publisher","first-page":"208","DOI":"10.4103\/2305-0500.356839","volume":"11","author":"MM Laqqan","year":"2022","unstructured":"Laqqan MM, Yassin MM. Anti-Mullerian hormone and antral follicle count predict ovarian response in women less than 45 years following GnRH antagonist multiple-dose protocol. Asian Pacific Journal of Reproduction. 2022;11(5):208\u201316.","journal-title":"Asian Pacific Journal of Reproduction"},{"key":"2684_CR81","doi-asserted-by":"crossref","unstructured":"Sun X, et al. Comparison of the predictive capability of antral follicle count vs. the anti-M\u00fcllerian hormone for ovarian response in infertile women. Front Endocrinol. 2022;13:862733.","DOI":"10.3389\/fendo.2022.862733"},{"issue":"86","key":"2684_CR82","doi-asserted-by":"publisher","DOI":"10.15557\/JoU.2021.0032","volume":"21","author":"R Izhar","year":"2021","unstructured":"Izhar R, et al. Antral follicle count and anti-M\u00fcllerian hormone level as predictors of ovarian hyperstimulation syndrome in women with polycystic ovarian syndrome undergoing controlled ovarian stimulation. Journal of Ultrasonography. 2021;21(86): e200.","journal-title":"Journal of Ultrasonography"},{"issue":"4","key":"2684_CR83","first-page":"231","volume":"13","author":"GA Ayd\u0131n","year":"2015","unstructured":"Ayd\u0131n GA, et al. Assessment of the relationship of basal serum anti-mullerian hormone levels with oocyte quality and pregnancy outcomes in patients undergoing ICSI. Iranian Journal of Reproductive Medicine. 2015;13(4):231\u20136.","journal-title":"Iranian Journal of Reproductive Medicine"},{"issue":"4","key":"2684_CR84","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.fertnstert.2003.08.044","volume":"81","author":"F Durmusoglu","year":"2004","unstructured":"Durmusoglu F, et al. Combining cycle day 7 follicle count with the basal antral follicle count improves the prediction of ovarian response. Fertil Steril. 2004;81(4):1073\u20138.","journal-title":"Fertil Steril"},{"issue":"3","key":"2684_CR85","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.fertnstert.2008.10.042","volume":"93","author":"K Jayaprakasan","year":"2010","unstructured":"Jayaprakasan K, et al. A prospective, comparative analysis of anti-M\u00fcllerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation. Fertil Steril. 2010;93(3):855\u201364.","journal-title":"Fertil Steril"},{"issue":"8","key":"2684_CR86","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3109\/09513590.2013.801443","volume":"29","author":"F Mart\u00ednez","year":"2013","unstructured":"Mart\u00ednez F, et al. Is AMH useful to reduce low ovarian response to GnRH antagonist protocol in oocyte donors? Gynecol Endocrinol. 2013;29(8):754\u20137.","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"2684_CR87","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.fertnstert.2018.03.031","volume":"110","author":"VL Baker","year":"2018","unstructured":"Baker VL, et al. Multicenter evaluation of the access AMH antim\u00fcllerian hormone assay for the prediction of antral follicle count and poor ovarian response to controlled ovarian stimulation. Fertil Steril. 2018;110(3):506-513.e3.","journal-title":"Fertil Steril"},{"key":"2684_CR88","doi-asserted-by":"crossref","unstructured":"Muttukrishna, S., et al., Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology? BJOG: An International Journal of Obstetrics and Gynaecology, 2005. 112(10): p. 1384\u20131390.","DOI":"10.1111\/j.1471-0528.2005.00670.x"},{"key":"2684_CR89","doi-asserted-by":"crossref","unstructured":"Kasapoglu I, et al. Are all antral follicles the same? Size of antral follicles as a key predictor for response to controlled ovarian stimulation. J Obstet Gynaecol. 2022;42(3):461\u20136.","DOI":"10.1080\/01443615.2021.1910640"},{"issue":"1","key":"2684_CR90","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1479-828X.2005.00332.x","volume":"45","author":"KP Tremellen","year":"2005","unstructured":"Tremellen KP, et al. Anti-mullerian hormone as a marker of ovarian reserve. Aust N Z J Obstet Gynaecol. 2005;45(1):20\u20134.","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"2684_CR91","doi-asserted-by":"crossref","unstructured":"Dermolo M, Ansa M, Siferih M. Ovarian response to controlled stimulation and its predictors in a limited-resource setting. BMC Women's Health. 2024;24(1):279.","DOI":"10.1186\/s12905-024-02991-7"},{"issue":"6","key":"2684_CR92","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1093\/humrep\/deab056","volume":"36","author":"SC Esteves","year":"2021","unstructured":"Esteves SC, et al. Antral follicle count and anti-M\u00fcllerian hormone to classify low-prognosis women under the POSEIDON criteria: a classification agreement study of over 9000 patients. Hum Reprod. 2021;36(6):1530\u201341.","journal-title":"Hum Reprod"},{"issue":"9","key":"2684_CR93","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1093\/humrep\/dead148","volume":"38","author":"A La Marca","year":"2023","unstructured":"La Marca A, et al. Predicting the total number of retrieved oocytes following double ovarian stimulation (DuoStim). Hum Reprod. 2023;38(9):1784\u20138.","journal-title":"Hum Reprod"},{"issue":"3","key":"2684_CR94","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s43032-022-01055-1","volume":"30","author":"MM Laqqan","year":"2023","unstructured":"Laqqan MM, Yassin MM. Investigation of the predictive factors of diminished ovarian reserve in women aged less than 40 years and undergoing ICSI cycle. Reprod Sci. 2023;30(3):873\u201382.","journal-title":"Reprod Sci"},{"issue":"1","key":"2684_CR95","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.fertnstert.2011.10.031","volume":"97","author":"MP Rosen","year":"2012","unstructured":"Rosen MP, et al. A characterization of the relationship of ovarian reserve markers with age. Fertil Steril. 2012;97(1):238\u201343.","journal-title":"Fertil Steril"},{"key":"2684_CR96","doi-asserted-by":"publisher","first-page":"601752","DOI":"10.3389\/fendo.2021.601752","volume":"12","author":"X Jiao","year":"2021","unstructured":"Jiao X, et al. Ovarian reserve markers in premature ovarian insufficiency: within different clinical stages and different etiologies. Front Endocrinol. 2021;12:601752\u2013601752.","journal-title":"Front Endocrinol"},{"issue":"11","key":"2684_CR97","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1210\/clinem\/dgaa513","volume":"105","author":"LME Moolhuijsen","year":"2020","unstructured":"Moolhuijsen LME, Visser JA. Anti-M\u00fcllerian hormone and ovarian reserve: update on assessing ovarian function. J Clin Endocrinol Metab. 2020;105(11):3361\u201373.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2684_CR98","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.repbio.2016.12.002","volume":"17","author":"K Keane","year":"2017","unstructured":"Keane K, et al. Specific ranges of anti-Mullerian hormone and antral follicle count correlate to provide a prognostic indicator for IVF outcome. Reprod Biol. 2017;17(1):51\u20139.","journal-title":"Reprod Biol"},{"issue":"26","key":"2684_CR99","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2104809118","volume":"118","author":"KN Hart","year":"2021","unstructured":"Hart KN, et al. Structure of AMH bound to AMHR2 provides insight into a unique signaling pair in the TGF-\u03b2 family. Proc Natl Acad Sci. 2021;118(26): e2104809118.","journal-title":"Proc Natl Acad Sci"},{"key":"2684_CR100","doi-asserted-by":"crossref","unstructured":"Malone SA, et al. Defective AMH signaling disrupts GnRH neuron development and function and contributes to hypogonadotropic hypogonadism. Elife. 2019;8:e47198.","DOI":"10.7554\/eLife.47198"},{"issue":"6","key":"2684_CR101","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nrendo.2011.224","volume":"8","author":"JA Visser","year":"2012","unstructured":"Visser JA, et al. Anti-M\u00fcllerian hormone: an ovarian reserve marker in primary ovarian insufficiency. Nat Rev Endocrinol. 2012;8(6):331\u201341.","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"2684_CR102","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1210\/en.2006-1265","volume":"148","author":"JA Visser","year":"2007","unstructured":"Visser JA, et al. Increased oocyte degeneration and follicular atresia during the estrous cycle in anti-M\u00fcllerian hormone null mice. Endocrinology. 2007;148(5):2301\u20138.","journal-title":"Endocrinology"},{"key":"2684_CR103","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.mce.2016.05.019","volume":"433","author":"E Hayes","year":"2016","unstructured":"Hayes E, et al. Intra-cellular mechanism of anti-M\u00fcllerian hormone (AMH) in regulation of follicular development. Mol Cell Endocrinol. 2016;433:56\u201365.","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"2684_CR104","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1093\/humupd\/dmu020","volume":"20","author":"SL Broer","year":"2014","unstructured":"Broer SL, et al. Anti-M\u00fcllerian hormone: ovarian reserve testing and its potential clinical implications. Hum Reprod Update. 2014;20(5):688\u2013701.","journal-title":"Hum Reprod Update"},{"issue":"4","key":"2684_CR105","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1365-2265.2007.03073.x","volume":"68","author":"CK Welt","year":"2008","unstructured":"Welt CK. Primary ovarian insufficiency: a more accurate term for premature ovarian failure. Clin Endocrinol. 2008;68(4):499\u2013509.","journal-title":"Clin Endocrinol"},{"issue":"6","key":"2684_CR106","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/humupd\/7.6.581","volume":"7","author":"A Bukman","year":"2001","unstructured":"Bukman A, Heineman M. Ovarian reserve testing and the use of prognostic models in patients with subfertility. Hum Reprod Update. 2001;7(6):581\u201390.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"2684_CR107","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12958-019-0534-3","volume":"17","author":"K Sakaguchi","year":"2019","unstructured":"Sakaguchi K, et al. Relationships between the antral follicle count, steroidogenesis, and secretion of follicle-stimulating hormone and anti-M\u00fcllerian hormone during follicular growth in cattle. Reprod Biol Endocrinol. 2019;17(1):88.","journal-title":"Reprod Biol Endocrinol"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-024-02684-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-024-02684-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-024-02684-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T08:11:33Z","timestamp":1734509493000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-024-02684-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":107,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2684"],"URL":"https:\/\/doi.org\/10.1186\/s13643-024-02684-0","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]},"assertion":[{"value":"22 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"303"}}